EMV has had plenty of time to partner or collaborate. The CEO/MD has stepped down so very unlikely there are opportunities in the near term.
Collaboration into new areas of imaging would be something that would be worth pursuing whilst EMV maintain 100% of stroke imaging is where I see the value creation. Licensing is another discussion.
But there isn’t much happening. You can muse about what colour lambo you’ll buy, but it won’t bring 2025/6 any closer.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)